Jason Karlawish wrote an op-ed on Biogen’s experimental drug, aducanumab, Newsweek
Jason Karlawish says that asking questions about our aches and pains is vital to healthy aging in Philadelphia Inquirer op-ed According to Research Associate Jason Karlawish's op-ed in
Jason Karlawish’s op-ed for The Hill: "Advancing Telemedicine Beyond Covid-19 is the Beginning of a Revolution in Dementia Care" In an op-ed for The Hill, PARC Reasearch Associate Jason Karlawish says that
Jason Karlawish’s op-ed in the Los Angeles Times urges caution when fast-tracking new medical treatments In a Los Angeles Times op-ed titled "Overhyped Alzheimer’s treatments betrayed patients’ hopes.
Jason Karlawish discusses the FDA’s decision to approve Alzheimer’s drug aducanumab in an op-ed for the journal Nature In "Fix the Process that Led to Alzheimer’s Drug Fiasco," an op-ed for the journal Nature, PARC Research Associate Jason Karlawish advocates for reforms to the FDA's acceler
Jason Karlawish guest on the Science Rehashed podcast, speaking about "Alzheimer’s Disease from the Inside Out PARC Research Associate Jason Karlawish participates in an episode of the Science Rehashed podcast that discusses the history
Jason Karlawish was featured in Penn Memory Center News discussing a new NIA funded project that studies the financial symptoms of Alzheimer’s disease Jason Karlawish (PARC Research Associates) was featured in the Penn Memory Center News discuss
Jason Karlawish discusses "Breaking Down Medicare’s Proposed Decision on Aducanumab and Monoclonal Antibody Treatments on the Dementia Matters podcast The Dementia Matters Podcast features PARC Research Associate Jason Karlawish in a discussion of the C
Jason Karlawish featured in LDI blog post "Learning Your Risk for Alzheimer’s Disease Jason Karlawish (PARC Research Associate) was featured in a Penn LDI Blog titled "L
Studies conducted by Jason Karlawish about Alzheimer’s cited in a blog about improving care for older adults Research studies conducted by Jason Karlawish (PARC Research Associate) published in PLOS ONE, Journal Of the American G
Jason Karlawish discusses the Alzheimer’s crisis in the US in the Boyarsky Lecture series
Jason Karlawish quoted in The New York Times and Vox Jason Karlawish (PARC Research Associate) was featured in The New York Times<
Jason Karlawish interviewed for the Innovatice Podcast about new book Jason Karlawish (PARC Research Associate) was interviewed on a recent 
Jason Karlawish was featured in Penn Today and The Penn Gazette Jason Karlawish (PARC) was featured in Penn Today and
New Study published by PARC Associates Nancy Hodgson and Jason Karlawish cited in a Blog about Improving Care for older Adults New study cataloguing patient experiences amongst those living in long term nursing or care facilities conducted by PARC Research Associates Nancy Hodgson and Jason Karlawish pu
Jason Karlawish wrote an article for The Hill Jason Karlawish (PARC Research Associate) co-authored an article for
Jason Karlawish and Allison Hoffman featured in The Washington Post PARC Research Associates Jason Karlawish and Allison K.
Jason Karlawish featured in The New York Times Jason Karlawish (PARC Research Associate) was quoted in a New York Times article about the
Jason Karlawish featured in Penn Today about allocating resources during a pandemic Jason Karlawish (PARC Research Associate) was featured in Penn Today<
Jason Karlawish Discusses What ICU Delirium Looks Like in Patients Jason Karlawish (PARC Research Associate) discusses his latest STAT op-ed and explains what ICU delirium looks like in patients with dementia.
Jason Karlwish Writes for Jama Neurology In a recent Viewpoint article for JAMA Network, Jason Karlawish (PARC Research Associate) writes on how to translate the discovery of covert consciousness to clinical pract
Jason Karlawish (PARC) discusses the history and present state of Alzheimer’s Disease Care Jason Karlawish (PARC) and Richard Bartholomew engaged in a conversation using personal experiences about the history and present state of Alzheimer's Disease Care.
Research by PARC Associate Jason Karlawish and co-author featured in New York Times Research by Jason Karlawish (PARC) and co-author featured in New York Times and LDI News.
PARC Associate Jason Karlawish speaks at a launch of the Roybal Center for Palliative Care in Dementia PARC Associate Jason Karlawish, who is the director of the Roybal Center Pilot Care presented on the history of the Alzheimer's treatment and care in a special lecture celebrating the launch. The new center - Ro
Research by PARC Associate Jason Karlawish and co-author featured in Penn Memory Center A recent study by Jason Karlawish (PARC Associate) and co-authors outlines current issues in participant notificiation following large-scale drug trials closure and identifies ways for all stakeholders to improve going forward.
PARC Associate Jason Karlawish quoted in CQ article In an artilce titled "An All-Out War on Alzheimer's at NIH" posted on CQ, comments from PARC Associate Jason Karlawish are mentioned. 
Research Study by Jason Karlawish Named Best Advance of 2019 in Cognitive Neurology/Dementia Study by Jason Karlawish (PARC Research Associate) and collaborators that investigated physician-assisted death attitudes among those with an Alzheimer disease biomarker was highlighted as a “Best Advance of 2019 in Cognitive Neurology/Dementia” b
Jason Karlawish featured in New York Times article Jason Karlawish did a formal study to gauge patients’ responses to learning that they had elevated levels of amyloid in their brain, i.e. he studied their response to the results of the Alzheimer's tests.
PARC Associate Jason Karlawish writes an article for STAT+ In an opinion article by Jason Karlawish for STAT+, he writes about how Aducanumab is not a simple solution to the complicated Alzheimer's c
PARC Associate Jason Karlawish testifies before Senate Dr. Jason Karlawish, MD, recently testified on the state of Alzheimer’s and dementia research and care in Washington, D.C. before the Senate Finance subcommittee on health care. Read more here
Penn Memory Center Co-Director & PARC Associate Jason Karlawish featured in Fatherly article Jason Karlawish in Fatherly article outlines tips for talking to older parents exhibiting early signs of dementia or Alzheimer's disease.
PARC Associate Jason Karlawish reappointed to the National Academies of Sciences, Engineering and Medicine Committee Rebecca A.
Senior’s weakness for scams may be warning sign of dementia Jason Karlawish said a recent study on aging and scam awareness doesn’t prove a link between susceptibility and cognitive decline in seniors in the Associated Press.
Banks monitor older customers for cognitive decline PARC Associate Jason Karlawish said that banks notifying health-care professionals when older clients show signs of decline would help doctors make diagnoses and better protect account holders in a
Reinterpreting Alzheimer’s PARC Associate, Jason Karlawish was quoted in an Opera Philadelphia blog post about art and its influence on alzheimers patients. 
How Bill Gates Could Transform Alzheimer’s Disease Jason Karlawish wrote an article in Forbes about how Bill Gates could alter the treatment of alzheimers.
How to Bring the Ballot to Aging Americans Jason Karlawish was quoted in a PEW Statel
Alzheimer’s Drug Shows Benefit, But Some Experts Say More Testing Needed Jason Karlawish was mentioned in a Wall Street Journal article about drugs for alzheimer's patients.
Many people who have dementia don’t know it. Here’s who’s most at risk Jason Karlawish was mentioned in a Philadelphia Inquiry article on the importance of dementia patients having "kno
Is It Dementia? Everyday Signs That Merit a Doctor Visit Jason Karlawish wrote an article for AARP on the symptoms of dementia.
Elder Financial Exploitation: Why it is a concern, what regulators are doing about it, and looking ahead Jason Karlawish's Forbes articles, "Why Bankers, Financial Analysts And Doctors Need To Start Working Together" and "
How to bring the ballot to aging Americans PARC Associate Jason Karlawish discussed the ethical imperative to help nursing-home residents vote in elections in a Huffington Post
Whealthcare: Preventing Financial Fraud And Promoting Cognitive Health And Wealth Jason Karlawish published an article in Forbes on preventing financial fraud in olde
Bio-Age Will Change Who We Are (And If We Have To Take Off Our Shoes At The Airport) PARC research associate, Jason Karlawish, has published a new article in Forbes ab
Why ‘Biomarkers’ Will Be Used to Detect Some Alzheimer’s Cases PARC Associate, Jason Karlawish was quoted in a Healthline article about new causes of dementia.
Carpe Dia, Or My Treatment For Alzheimer’s Disease PARC Associate, Jason Karlawish, wrote an article in Forbes about the treatment of Alzheimers.
Is it okay to tell an Alzheimer’s patient a white lie? Jason Karlawish is mentioned in a Washington Post article abo
Spend Some Money To Make Money, Or The Opportunities Of Whealthcare Jason Karlawish authored an article in Forbes about health and wealth, or as he calls it "
What If You Knew Alzheimer’s Was Coming for You? Jason Karlawish of the Perelman School of Medicine comments on how people at high risk of Alzheimer’s disease manage with that kn